News from biogen canada A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jun 13, 2019, 06:00 ET Ontario grants broader access to SPINRAZA™ (nusinersen) for patients living with spinal muscular atrophy (SMA)

Access to the first and only approved treatment for pre-symptomatic, Type I, II, and III SMA patients under the age of 18 Ontario joins Saskatchewan and Quebec to give patients with SMA broader...


Apr 22, 2019, 07:00 ET Patients living with Spinal Muscular Atrophy (SMA) in the province of Saskatchewan gain access to SPINRAZA™ (nusinersen)

The Government of the province of Saskatchewan has informed treating physicians that it will grant access to SPINRAZA™ to patients living with Spinal Muscular Atrophy (SMA) Saskatchewan is the second ...


Oct 03, 2018, 08:00 ET Biogen Canada and pan-Canadian Pharmaceutical Alliance (pCPA) Reach Agreement on Access to First and Only Approved Treatment for Spinal Muscular Atrophy (SMA) in Canada

Treatment provides hope for patients suffering from devastating genetic disorder Public drug plans will cover Type 1 patients and Biogen will cover the most urgent Type 2 and 3 patients under an...


Feb 23, 2018, 12:25 ET Biogen Canada Applauds Publication of SPINRAZA™ (nusinersen) Phase 3 Study Results in Individuals with Later-Onset Spinal Muscular Atrophy in 'New England Journal of Medicine', Views Evidence as

Biogen Canada today applauded the recent release of end of study results from CHERISH, the Phase 3 study evaluating SPINRAZA™ (nusinersen) for the treatment of individuals with later-onset spinal...


Feb 03, 2016, 08:00 ET Extended Half-Life Factor Products ALPROLIX™ and ELOCTATE™ Available to Canadians with Hemophilia

Canadian Blood Services Approves Listing and Distribution of Innovative Extended Half-Life Therapies MISSISSAUGA, ON, Feb. 3, 2016 /CNW/ - Biogen Canada is pleased to announce the completion of...


Jun 03, 2015, 08:00 ET Quebec Government to Cover TECFIDERA™ as a First-Line Oral Treatment for Multiple Sclerosis

Important Step for those Living with MS in Quebec MISSISSAUGA, ON, June 3, 2015 /CNW/ - Biogen Canada announces today that Quebec's Institut national d'excellence en santé et services sociaux...